As previously demonstrated Mif−/−STZ developed less severe hyperglycemia, reduced levels of IFN-γ and TNF-α, a smaller amount of pancreatic islet antigen- (PIAg-) specific IgG, and decreased cell infiltration into the pancreatic islets compared to WtSTZ. This evidence concerns the gene MIF and Hyperglycemia.